Osteoclasts are essential for TNF-α-mediated joint destruction.
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The detailed cellular and molecular mechanisms leading to joint destruction in rheumatoid arthritis, a disease driven by proinflammatory cytokines, are still unknown. To address the question of whether osteoclasts play a pivotal role in this process, transgenic mice that express human TNF (hTNFtg) and that develop a severe and destructive arthritis were crossed with osteopetrotic, c-fos–deficient mice (c-fos–/–) completely lacking osteoclasts. The resulting mutant mice (c-fos–/–hTNFtg) developed a TNF-dependent arthritis in the absence of osteoclasts. All clinical features of arthritis, such as paw swelling and reduction of grip strength, progressed equally in both groups. Histological evaluation of joint sections revealed no difference in the extent of synovial inflammation, its cellular composition (except for the lack of osteoclasts), and the expression of matrix metalloprotein-ase-3 (MMP-3) and MMP-13. In addition, cartilage damage, proteoglycan loss, and MMP-3, -9, and -13 expression in chondrocytes were similar in hTNFtg and c-fos–/–hTNFtg mice. However, despite the presence of severe inflammatory changes, c-fos–/–hTNFtg mice were fully protected against bone destruction. These data reveal that TNF-dependent bone erosion is mediated by osteoclasts and that the absence of osteoclasts alters TNF-mediated arthritis from a destructive to a nondestructive arthritis. Therefore, in addition to the use of anti-inflammatory therapies, osteoclast inhibition could be beneficial for the treatment of rheumatoid arthritis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Certainly the high circulating levels of TNF-␣ and IL-1 that are common in RA have the potential to promote osteoclastogenesis throughout the skeleton (223,237,(423)(424)(425).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [425]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Self-citation
Research works printed but not linked: 4
- Okada, 1995, Lab Invest, 72, 311
- Pap, 1999, J Rheumatol, 26, 166
- Gravallese, 1998, Am J Pathol, 152, 943
- Douni, 1995, J Inflamm, 47, 27
Cited by
Items 101–200 of 478
L-arginine metabolism inhibits arthritis and inflammatory bone loss
Cao, S., Li, Y., Song, R., Meng, X., Fuchs, M., Liang, C., Kachler, K., Meng, X., Wen, J., Schlötzer-Schrehardt, U. M., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223626 · Cited by 113
Self-citationNF-κB–inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis
Aya, K., Alhawagri, M., Hagen-Stapleton, A., Kitaura, H., Kanagawa, O., & Veis Novack, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23763 · Cited by 112
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy
Herman, S., Krönke, G., & Schett, G. A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.04.001 · Cited by 123
Self-citationc-Fos suppresses systemic inflammatory response to endotoxin
Ray, N., Kuwahara, M., Takada, Y., Maruyama, K., Kawaguchi, T., Tsubone, H., Ishikawa, H., & Matsuo, K. (2006) · International Immunology · doi:10.1093/intimm/dxl004 · Cited by 110
Multifunctional Janus Nanoplatform for Efficiently Synergistic Theranostics of Rheumatoid Arthritis
Liu, Y., Chen, L., Chen, Z., Liu, M., Li, X., Kou, Y., Hou, M., Wang, H., Li, X., Tian, B., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c11777 · Cited by 111
Karsdal, M. A., Schett, G. A., Emery, P., Harari, O., Byrjalsen, I., Kenwright, A., Bay‐Jensen, A., & Platt, A. (2012) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.01.004 · Cited by 110
Self-citationBone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
Baum, R., & Gravallese, E. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8515-6 · Cited by 101
Herman, S., Müller, R. B., Krönke, G., Zwerina, J., Redlich, K., Hueber, A. J., Gelse, H., Neumann, E., Müller‐Ladner, U., & Schett, G. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23943 · Cited by 98
Self-citationShi, Y., Xie, F., Rao, P., Qian, H., Chen, R., Hu, C., Li, D., Mu, D., Zhang, L., Lv, P., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.054 · Cited by 101
Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review
Nevius, E., Gomes, A. C., & Pereira, J. P. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8520-9 · Cited by 113
Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link
Sapir‐Koren, R., & Livshits, G. (2017) · Bone · doi:10.1016/j.bone.2017.06.020 · Cited by 106
Hayer, S., Redlich, K., Korb, A., Hermann, S., Smolen, J. S., & Schett, G. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22313 · Cited by 105
Self-citationHoff, M., Kvien, T. K., Kälvesten, J., Elden, A. M. B., & Haugeberg, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091264 · Cited by 98
Komatsu, N., & Takayanagi, H. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394299-9.00002-3 · Cited by 104
Miranda‐Carús, M., Benito‐Miguel, M., Balsa, A., Cobo‐Ibáñez, T., Pérez De Ayala, C., Pascual‐Salcedo, D., & Martín‐Mola, E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21731 · Cited by 92
Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection
Jones, D., Glimcher, L. H., & Aliprantis, A. O. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46262 · Cited by 91
An update on the cytokine network in rheumatoid arthritis
Miossec, P. (2004) · Current Opinion in Rheumatology · doi:10.1097/00002281-200405000-00009 · Cited by 92
Signalling platforms that modulate the inflammatory response: new targets for drug development
McCulloch, C. A., Downey, G. P., & El-Gabalawy, H. S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2109 · Cited by 104
Proulx, S. T., Kwok, E., You, Z., Papuga, M. O., Beck, C. A., Shealy, D. J., Ritchlin, C. T., Awad, H. A., Boyce, B. F., Xing, L., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23128 · Cited by 90
Wang, N., Zhou, Z., Wu, T., Liu, W. X., Yin, P., Pan, C., & Yu, X. (2016) · Open Biology · doi:10.1098/rsob.150258 · Cited by 89
RetractedOsteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0089-z · Cited by 94
Rheumatoid arthritis therapy after tumor necrosis factor and interleukin‐1 blockade
Redlich, K., Schett, G. A., Steiner, G. E., Hayer, S., Wagner, E. F., & Smolen, J. S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11358 · Cited by 94
Self-citationThe α-Isoform of p38 MAPK Specifically Regulates Arthritic Bone Loss
Böhm, C., Hayer, S., Kilian, A., Zaiss, M. M., Finger, S., Hess, A., Engelke, K., Kollias, G., Krönke, G., Zwerina, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901026 · Cited by 85
Self-citationMacrophage lineage phenotypes and osteoclastogenesis—Complexity in the control by GM-CSF and TGF-β
Lari, R., Fleetwood, A. J., Kitchener, P. D., Cook, A. D., Pavasovic, D., Hertzog, P. J., & Hamilton, J. A. (2006) · Bone · doi:10.1016/j.bone.2006.09.003 · Cited by 94
Insights into the treatment of rheumatoid arthritis: A paradigm in medicine
Smolen, J. S. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102425 · Cited by 86
Self-citationShen, P. F., Jiao, Y., Li, M., Chen, J., & Momtazi‐Borojeni, A. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15803 · Cited by 88
Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis
Yang, M., & Zhu, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052688 · Cited by 98
Chia-Lan, T., Chen, W., Hsieh, H., Chi, P., Hsiao, L., & Yang, C. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-12 · Cited by 83
RANKL: A therapeutic target for bone destruction in rheumatoid arthritis
Tanaka, S., Tanaka, Y., Ishiguro, N., Yamanaka, H., & Takeuchi, T. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1369491 · Cited by 83
Non-classical monocytes as mediators of tissue destruction in arthritis
Puchner, A., Saferding, V., Bonelli, M. M., Mikami, Y., Hofmann, M., Brunner, J. S., Caldera, M., Gonçalves‐Alves, E., Binder, N. B., Fischer, A., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213250 · Cited by 87
Self-citationBiologic therapies and systemic bone loss in rheumatoid arthritis
Dimitroulas, T., Nikas, S. N., Trontzas, P., & Kitas, G. D. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.015 · Cited by 86
Infliximab: 12 years of experience
Smolen, J. S., & Emery, P. (2011) · Arthritis Research & Therapy · doi:10.1186/1478-6354-13-s1-s2 · Cited by 87
Self-citationDeng, W., Ding, Z., Wang, Y., Zou, B., Zheng, J., Tan, Y., Yang, Q. Z., Ke, M., Chen, Y., Wang, S., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153838 · Cited by 81
Vandooren, B., Cantaert, T., Noordenbos, T., Tak, P. P., & Baeten, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23290 · Cited by 84
Inflammation-Induced Bone Loss: Can it Be Prevented?
Romas, E., & Gillespie, M. T. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.07.004 · Cited by 87
Role of RANKL in bone diseases
Anandarajah, A. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.007 · Cited by 84
Gan, K., Xu, L., Feng, X., Zhang, Q., Wang, F., Zhang, M., & Tan, W. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.12.012 · Cited by 78
Urushibara, M., Takayanagi, H., Koga, T., Kim, S., Isobe, M., Morishita, Y., Nakagawa, T., Loeffler, M. L., Kodama, T., Kurosawa, H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20206 · Cited by 78
Blüml, S., Binder, N. B., Niederreiter, B., Polzer, K., Hayer, S., Tauber, S., Schett, G. A., Scheinecker, C., Kollias, G. A., Selzer, E., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27399 · Cited by 78
Self-citationSchett, G. A., Stolina, M., Dwyer, D., Zack, D. J., Uderhardt, S., Krönke, G., Kostenuik, P. J., & Feige, U. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24767 · Cited by 79
Self-citationPre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease
Moschen, A. R., Geiger, S., Gerner, R. R., & Tilg, H. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.06.012 · Cited by 77
Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis
Boumans, M. J. H., Thurlings, R. M., Yeo, L., Scheel‐Toellner, D., Vos, K., Gerlag, D. M., & Tak, P. P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200198 · Cited by 84
Hoff, M., Haugeberg, G., & Kvien, T. K. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2280 · Cited by 84
The dynamic interplay between osteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.04.004 · Cited by 78
Lu, X., Beck, G. R., Gilbert, L. C., Camalier, C. E., Bateman, N. W., Hood, B. L., Conrads, T. P., Kern, M. J., You, S., Chen, H., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.203 · Cited by 81
Inhibition of osteoclast differentiation and bone resorption by sauchinone
Han, K.-Y., Yang, D., Chang, E.-J., Lee, Y., Huang, H., Sung, S. H., Lee, Z. H., Kim, Y. C., & Kim, H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.044 · Cited by 74
Leiss, H., Niederreiter, B., Bandur, T., Schwarzecker, B., Blüml, S., Steiner, G. E., Ulrich, W., Smolen, J., & Stummvoll, G. H. (2013) · Lupus · doi:10.1177/0961203313492869 · Cited by 70
Self-citationEffects of anti-tumor necrosis factor α agents on bone
Kawai, V. K., Stein, C. M., Perrien, D. S., & Griffin, M. R. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328356d212 · Cited by 67
Zheng, H., Liu, Y., Deng, Y., Li, Y., Liu, S., Yang, Y., Qiu, Y., Li, B., Sheng, W., Liu, J., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00788-w · Cited by 75
Kim, S.-J., Chen, Z., Chamberlain, N. D., Essani, A. B., Volin, M. V., Amin, M. A., Volkov, S., Gravallese, E. M., Arami, S., Swedler, W., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302998 · Cited by 69
Pathogenesis of Joint Destruction in Rheumatoid Arthritis
Shiozawa, S., Tsumiyama, K., Yoshida, K., & Hashiramoto, A. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0116-3 · Cited by 76
Cell‐to‐cell communication in guided bone regeneration: molecular and cellular mechanisms
Gruber, R., Stadlinger, B., & Terheyden, H. (2016) · Clinical Oral Implants Research · doi:10.1111/clr.12929 · Cited by 76
CD44 is a determinant of inflammatory bone loss
Hayer, S., Steiner, G., Görtz, B., Reiter, E., Tohidast-Akrad, M., Amling, M., Hoffmann, O., Redlich, K., Zwerina, J., Skriner, K., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040852 · Cited by 66
Self-citationKrönke, G., Uderhardt, S., Kim, K., Stock, M., Scholtysek, C., Zaiss, M. M., Surmann‐Schmitt, C., Luther, J., Katzenbeisser, J., David, J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27496 · Cited by 74
Self-citationKoufany, M., Moulin, D., Bianchi, A., Muresan, M., Sebillaud, S., Netter, P., Weryha, G., & Jouzeau, J.-Y. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2354 · Cited by 66
Osteoclasts in arthritis and Th17 cell development
Okamoto, K., & Takayanagi, H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.010 · Cited by 74
Bonelli, M. M., Ferner, E., Göschl, L., Blüml, S., Hladik, A., Karonitsch, T., Kiener, H. P., Byrne, R. A., Niederreiter, B., Steiner, C. W., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37787 · Cited by 65
Self-citationOduro, K. A., Liu, F., Tan, Q., Kim, C.-K., Lubman, O., Fremont, D., Mills, J. C., & Choi, K. (2012) · Blood · doi:10.1182/blood-2011-11-391342 · Cited by 65
Alves, C. H., Farrell, E., Vis, M., Colin, E. M., & Lubberts, E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8522-7 · Cited by 71
Analysis of the kinetics of osteoclastogenesis in arthritic rats
Schett, G. A., Stolina, M., Bolon, B. N., Middleton, S. C., Adlam, M., Brown, H., Zhu, L., Feige, U., & Zack, D. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21343 · Cited by 69
Self-citationNozawa, K., Fujishiro, M., Kawasaki, M., Kaneko, H., Iwabuchi, K., Yanagida, M., Suzuki, F., Miyazawa, K., Takasaki, Y., Ogawa, H., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2863 · Cited by 65
Finzel, S., Kraus, S., Schmidt, S., Hueber, A. J., Rech, J., Engelke, K., Englbrecht, M., & Schett, G. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201580 · Cited by 64
Self-citationTumor necrosis factor biology in experimental and clinical arthritis
Sfikakis, P. P., & Kollias, G. A. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200307000-00003 · Cited by 64
Self-citationKing, T. J., Georgiou, K. R., Cool, J. C., Scherer, M. A., Ang, E. S. M., Foster, B. K., Xu, J., & Xian, C. J. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.037 · Cited by 71
Smolen, J. S., van der Heijde, D. M. F. M., Aletaha, D., Xu, S., Han, J. S., Baker, D., & Clair, E. W. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094128 · Cited by 69
Self-citationHistone deacetylases (HDAC) in physiological and pathological bone remodelling
Cantley, M. D., Zannettino, A. C. W., Bartold, P. M., Fairlie, D. P., & Haynes, D. R. (2016) · Bone · doi:10.1016/j.bone.2016.11.028 · Cited by 66
Hoffmann, M. H., Tuncel, J., Skriner, K., Tohidast-Akrad, M., Türk, B., Piñol-Roma, S., Serre, G., Schett, G. A., Smolen, J. S., Holmdahl, R., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7568 · Cited by 63
Self-citationGoff, B. L., Soltner, E., Charrier, C., Maugars, Y., Rédiní, F., Heymann, D., & Berthelot, J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2877 · Cited by 64
Osteoclastogenesis and arthritis
Maruotti, N., Grano, M., Colucci, S. C., Donofrıo, F., & Cantatore, F. P. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0117-2 · Cited by 72
Bone remodelling in inflammatory arthritis
Goldring, S. R., Purdue, P. E., Crotti, T. N., Shen, Z., Flannery, M. R., Binder, N. B., Ross, F. P., & McHugh, K. P. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202199 · Cited by 67
Qiu, S. X., Dan, C., Ding, L., Peng, S., Chen, S., Farnsworth, N. R., Nolta, J. A., Gross, M. L., & Zhou, P. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.010 · Cited by 68
Effects of inflammation on bone: an update
Baker-LePain, J. C., Nakamura, M. C., & Lane, N. E. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283474dbe · Cited by 63
An Anti-c-Fms Antibody Inhibits Orthodontic Tooth Movement
Kitaura, H., Yoshimatsu, M., Fujimura, Y., Eguchi, T., Kohara, H., Yamaguchi, A., & Yoshida, N. (2008) · Journal of Dental Research · doi:10.1177/154405910808700405 · Cited by 62
Zhao, Z., Hou, X., Yin, X., Li, Y., Duan, R., Boyce, B. F., & Yao, Z. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135728 · Cited by 57
Lower limb arterial incompressibility and obstruction in rheumatoid arthritis
del Rincón, I., Haas, R. W., Pogosian, S. A., & Escalante, A. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018671 · Cited by 68
Schett, G. A., Middleton, S. C., Bolon, B. N., Stolina, M., Brown, H., Zhu, L., Pretorius, J., Zack, D. J., Kostenuik, P. J., & Feige, U. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21021 · Cited by 62
Self-citationBone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates
Romas, E. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.06.008 · Cited by 64
Arthritis Induces Lymphocytic Bone Marrow Inflammation and Endosteal Bone Formation
Görtz, B., Hayer, S., Redlich, K., Zwerina, J., Tohidast-Akrad, M., Tuerk, B., Hartmann, C., Kollias, G. A., Steiner, G. E., Smolen, J. S., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040205 · Cited by 58
Self-citationAndreev, D., Kachler, K., Schett, G. A., & Bözec, A. (2022) · Bone · doi:10.1016/j.bone.2022.116468 · Cited by 64
Self-citationCitrullination of autoantigens: Upstream of TNFα in the pathogenesis of rheumatoid arthritis
Quirke, A., Fisher, B. A., Kinloch, A. J., & Venables, P. J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.006 · Cited by 68
Sun, M., Yang, J., Wang, J., Hao, T., Jiang, D., Bao, G., & Liu, G. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.011 · Cited by 57
RANKL as a therapeutic target of rheumatoid arthritis
Tanaka, S., & Tanaka, Y. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01159-1 · Cited by 59
LPS-Induced Inhibition of Osteogenesis Is TNF-α Dependent in a Murine Tooth Extraction Model
Tomomatsu, N., Aoki, K., Alles, N., Soysa, N. S., Hussain, A., Nakachi, H., Kita, S., Shimokawa, H., Ohya, K., & Amagasa, T. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090410 · Cited by 56
Mechanisms of bone loss in rheumatoid arthritis
Findlay, D. M., & Haynes, D. R. (2005) · Modern Rheumatology · doi:10.1007/s10165-005-0412-z · Cited by 58
Binder, N. B., Puchner, A., Niederreiter, B., Hayer, S., Leiss, H., Blüml, S., Kreindl, R., Smolen, J. S., & Redlich, K. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37797 · Cited by 60
Self-citationTumor necrosis factor α drives cadherin 11 expression in rheumatoid inflammation
Vandooren, B., Cantaert, T., ter Borg, M., Noordenbos, T., Kuhlman, R., Gerlag, D. M., Bongartz, T., Reedquist, K. A., Tak, P. P., & Baeten, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23886 · Cited by 64
Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions
Paine, A., & Ritchlin, C. T. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0380-2 · Cited by 59
Shibata, H., Yoshioka, Y., Abe, Y., Ohkawa, A., Nomura, T., Minowa, K., Mukai, Y., Nakagawa, S., Taniai, M., Ohta, T., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.041 · Cited by 54
Osteoinmunología: el estudio de la relación entre el sistema inmune y el tejido óseo
Arboleya, L. R., & Castañeda, S. (2013) · Reumatología Clínica · doi:10.1016/j.reuma.2013.02.008 · Cited by 62
Reduction of arthritis severity in protease‐activated receptor–deficient mice
Yang, Y. H., Hall, P., Little, C. B., Fosang, A., Milenkovski, G., Santos, L. L., Xue, J., Tipping, P. G., & Morand, E. F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21001 · Cited by 51
Ho, T., Santora, K. A., Chen, J. C., Frankshun, A., & Bagnell, C. A. (2011) · Bone · doi:10.1016/j.bone.2011.03.684 · Cited by 51
Osteoimmunology: The Study of the Relationship Between the Immune System and Bone Tissue
Arboleya, L. R., & Castañeda, S. (2013) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2013.02.004 · Cited by 67
Benefit of pregnancy in inflammatory arthritis
Straub, R. H., Buttgereit, F., & Cutolo, M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037580 · Cited by 53
Blüml, S., Friedrich, M., Lohmeyer, T., Sahin, E., Saferding, V., Brunner, J. S., Puchner, A., Mandl, P., Niederreiter, B., Smolen, J. S., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203486 · Cited by 50
Self-citationGoldring, S. R. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099408 · Cited by 55
Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis
Niu, Q., Gao, J., Wang, L., Liu, J., & Zhang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1034050 · Cited by 54
Matsuda, K., Shiba, N. N., & Hiraoka, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065173 · Cited by 55
Mukai, T., Gallant, R., Ishida, S., Kittaka, M., Yoshitaka, T., Fox, D. A., Morita, Y., Nishida, K., Rottapel, R. K., & Ueki, Y. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38975 · Cited by 59
Gümüş, P., Buduneli, E., Bıyıkoğlu, B., Aksu, K., Saraç, F., Nile, C. J., Lappin, D. F., & Buduneli, N. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.120595 · Cited by 49
Ezzat, Y., & HAMDY, K. (2010) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2010.01542.x · Cited by 49
Metadata
- Authors
- Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G.
- Affiliations
- University of Vienna (AT)
- Vienna Biocenter (AT)
- Research Institute of Molecular Pathology (AT)
- Alexander Fleming Biomedical Sciences Research Center (GR)
- Corresponding author
- Schett, Georg
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2002-11-15
- Volume
- 110
- Issue
- 10
- Pages
- 1419-1427
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4248559208
- Cited by
- 474
- References
- 40
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 11 · 2023: 11 · 2022: 11 · 2021: 12 · 2020: 24 · 2019: 16 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 24 · 2014: 22 · 2013: 25 · 2012: 29
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- Austrian Science Fund
- Oesterreichische Nationalbank
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Keywords
- osteoclasts, TNF-α, rheumatoid arthritis, joint destruction, bone erosion, osteopetrotic mice, transgenic mice, synovitis, cartilage damage, matrix metalloproteinases, MMP-13, MMP-3, MMP-9, chondrocytes, osteoclast inhibition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.